
Are Stocks Still Vulnerable 4/1/26
Halftime Report
00:00
Biotech Bounce After Eli Lilly Approval
Joe outlines biotech ETF strength after Eli Lilly's GLP‑1 pill approval and renewed deal activity fueling confidence.
Play episode from 38:35
Transcript


